The industry drew the ire of 44 state attorneys general alleging widespread conspiracy to inflate drug prices.
News & Analysis: Teva Pharmaceutical Industries
Tough industry conditions took their toll on some stocks.
A larger-than-expected legal settlement might be a harbinger of things to come.
Which of these fallen stars has the more compelling comeback story?
Forty-four states have brought a lawsuit against the industry.
Stocks took a beating thanks to China trade worries, with Boeing falling on further 737 MAX concerns and Teva Pharmaceutical and other generic-drug makers tumbling after getting sued.
An alleged price-fixing scheme is the weighing on the drugmaker's shares today.
Teva's turnaround won't kick into high gear anytime soon.
TEVA earnings call for the period ending March 31, 2019.
If you're looking to follow a master, Buffett is a good place to start. Though sometimes it pays to go back and double-check his moves.